United States Immuno Chemistry Market Outlook to 2024

United States Immuno Chemistry Market Outlook to 2024

Summary

GlobalDatas new report, United States Immuno Chemistry Market Outlook to 2024, provides key market data on the United States Immuno Chemistry market. The report provides value, in millions of US dollars, volume (in units) and average prices (USD) within market segments - Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests

The report also provides company shares and distribution shares data for each of these market segments, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular market and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

- Market size and company share data for Immuno Chemistry market segments - Complement Deficiency Tests, Diabetes Assays, Disease Specific Immunochemistry, Endocrinology Tests, IgE Allergy Blood Tests, Immunochemistry Analyzers, Immunochemistry Rapid Tests & POC and Vitamins Tests.
- Annualized market revenues (USD million) and volume (units) data for each of the market segments. Data is provided from 2010 to 2017 and forecast to 2024.
- 2017 company shares and distribution shares data for each of the market segments.
- Global corporate-level profiles of key companies operating within the United States Immuno Chemistry market.
- Key players covered include Siemens Healthcare GmbH, F. Hoffmann-La Roche Ltd, Abbott Laboratories and Thermo Fisher Scientific Inc.

Reasons to buy

- Develop business strategies by identifying the key market segments poised for strong growth in the future.
- Develop market-entry and market expansion strategies.
- Design competition strategies by identifying who-stands-where in the market.
- Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
- What are the key distribution channels and whats the most preferred mode of product distribution - Identify, understand and capitalize.

2
1.List of Tables 2
1.2 List of Figures 5
2 Introduction 6
2.What Is This Report About? 6
2.2 Immuno Chemistry Market Segmentation 6
2.3 Definitions of Markets Covered in the Report 8
3 Immuno Chemistry Market, United States 12
3.Immuno Chemistry Market, United States, Revenue ($m), 2010-2017 12
3.2 Immuno Chemistry Market, United States, Revenue ($m), 2017-2024 14
3.3 Immuno Chemistry Market, United States, Volume (Units), 2010-2017 48
3.4 Immuno Chemistry Market, United States, Volume (Units), 2017-2024 50
3.5 Immuno Chemistry Market, United States, Average Price ($), 2010-2024 84
3.6 Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), 2017 89
3.7 Immuno Chemistry Market, United States, Company Share by Revenue ($m), 2017 90
4 Overview of Key Companies in United States, Immuno Chemistry Market 92
4.Siemens Healthcare GmbH 92
4.2 F. Hoffmann-La Roche Ltd 92
4.3 Abbott Laboratories 92
4.4 Beckman Coulter Inc 92
4.5 DiaSorin S.p.A 93
4.6 Thermo Fisher Scientific Inc 93
4.7 bioMerieux SA 93
4.8 Bio-Rad Laboratories Inc 93
4.9 Ortho-Clinical Diagnostics Inc 94
4.10 Alere Inc 94
5 Immuno Chemistry Market Pipeline Products 95
6 Financial Deals Landscape 98
6.Acquisition 98
6.2 Debt Offerings 99
6.3 Equity Offerings 136
6.4 Merger 153
6.5 Partnerships 154
6.6 Venture Financing 156
7 Recent Developments 163
7.Corporate Communications 163
7.2 Financial Announcements 194
7.3 Government and Public Interest 297
7.4 Legal And Regulatory 299
7.5 Other Significant Developments 307
7.6 Product News 316
7.7 Strategy And Business Planning 323
8 Appendix 329
8.Research Methodology 330
8.2 GlobalData Consulting 334
8.3 Contact Us 335
8.4 Disclaimer 335

List Of Tables

1.1 List of Tables
Table 1: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 20
Table 2: Immuno Chemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 22
Table 3: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 24
Table 4: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 26
Table 5: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 28
Table 6: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 30
Table 7: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 32
Table 8: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 34
Table 9: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 36
Table 10: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Historic, 2010-2017 38
Table 11: Complement Deficiency Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 40
Table 12: Diabetes Assays Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 42
Table 13: Disease Specific Immunochemistry Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 44
Table 14: Endocrinology Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 46
Table 15: IgE Allergy Blood Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 48
Table 16: Immunochemistry Analyzers Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 50
Table 17: Immunochemistry Rapid Tests & POC Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 52
Table 18: Vitamins Tests Market, United States, Revenue ($m), USD Constant, Forecast, 2017-2024 54
Table 19: Immuno Chemistry Market, United States, Volume (Units), Historic, 2010-2017 56
Table 20: Immuno Chemistry Market, United States, Volume (Units), Forecast, 2017-2024 58
Table 21: Complement Deficiency Tests Market, United States, Volume (Units), Historic, 2010-2017 60
Table 22: Diabetes Assays Market, United States, Volume (Units), Historic, 2010-2017 62
Table 23: Disease Specific Immunochemistry Market, United States, Volume (Units), Historic, 2010-2017 64
Table 24: Endocrinology Tests Market, United States, Volume (Units), Historic, 2010-2017 66
Table 25: IgE Allergy Blood Tests Market, United States, Volume (Units), Historic, 2010-2017 68
Table 26: Immunochemistry Analyzers Market, United States, Volume (Units), Historic, 2010-2017 70
Table 27: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Historic, 2010-2017 72
Table 28: Vitamins Tests Market, United States, Volume (Units), Historic, 2010-2017 74
Table 29: Complement Deficiency Tests Market, United States, Volume (Units), Forecast, 2017-2024 76
Table 30: Diabetes Assays Market, United States, Volume (Units), Forecast, 2017-2024 78
Table 31: Disease Specific Immunochemistry Market, United States, Volume (Units), Forecast, 2017-2024 80
Table 32: Endocrinology Tests Market, United States, Volume (Units), Forecast, 2017-2024 82
Table 33: IgE Allergy Blood Tests Market, United States, Volume (Units), Forecast, 2017-2024 84
Table 34: Immunochemistry Analyzers Market, United States, Volume (Units), Forecast, 2017-2024 86
Table 35: Immunochemistry Rapid Tests & POC Market, United States, Volume (Units), Forecast, 2017-2024 88
Table 36: Vitamins Tests Market, United States, Volume (Units), Forecast, 2017-2024 90
Table 37: Immuno Chemistry Market, United States, Average Price ($) Historic, 2010-2017 91
Table 38: Immuno Chemistry Market, United States, Average Price ($), Forecast, 2017-2024 94
Table 39: Immuno Chemistry Market, United States, Distribution Share by Revenue ($m), USD Constant, 2017 96
Table 40: Immuno Chemistry Market, United States, Company Share by Revenue ($m), USD Constant, 2017 98
Table 41: Immuno Chemistry Market Pipeline Products 102
Table 42: One Lambda Acquires Linkage Biosciences 105
Table 43: Amgen Raises USD1 Billion in Public Offering of 3.2% Notes Due 2027 106
Table 44: Hologic Raises USD350 Million in Private Placement of 4.375% Notes Due 2025 108
Table 45: MEDITE Cancer Diagnostics Raises USD5.4 Million in Private Placement of Convertible Promissory Notes 109
Table 46: LabCorp Raises USD600 Million in Public Offering of 3.25% Notes Due 2024 110
Table 47: LabCorp Raises USD600 Million in Public Offering of 3.6% Notes Due 2027 112
Table 48: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 4.1% Notes Due 2047 114
Table 49: Thermo Fisher Scientific Raises USD750 Million in Public Offering of 3.2% Notes Due 2027 116
Table 50: Thermo Fisher Scientific Raises USD573.3 Million in Public Offering of Floating Rate Notes Due 2019 118
Table 51: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.4% Notes Due 2026 120
Table 52: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 1.95% Notes Due 2029 123
Table 53: Thermo Fisher Scientific Raises USD802.6 Million in Public Offering of 2.875% Notes Due 2037 126
Table 54: Becton, Dickinson to Raise USD725 Million in Public Offering of 2.133% Notes Due 2019 129
Table 55: Becton, Dickinson to Raise USD1 Billion in Public Offering of 2.404% Notes Due 2020 130
Table 56: Becton, Dickinson to Raise USD1.8 Billion in Public Offering of 2.894% Notes Due 2022 131
Table 57: Becton, Dickinson to Raise USD500 Million in Public Offering of Floating Rate Notes Due 2022 132
Table 58: Becton, Dickinson to Raise USD1.75 Billion in Public Offering of 3.363% Notes Due 2024 133
Table 59: Becton, Dickinson to Raise USD2.4 Billion in Public Offering of 3.7% Notes Due 2027 134
Table 60: Becton, Dickinson to Raise USD1.5 Billion in Public Offering of 4.669% Notes Due 2047 135
Table 61: Becton, Dickinson to Raise USD788 Million in Public Offering of 0.368% Notes Due 2019 136
Table 62: Thermo Fisher Scientific Prices Public Offering of 1.45% Notes Due 2027 for USD530 Million 137
Table 63: Becton Dickinson Prices Public Offering of 1% Notes Due 2022 for USD500 Million 139
Table 64: Becton Dickinson Prices Public Offering of 1.9% Notes Due 2026 for USD500 Million 141
Table 65: Trovagene Files Registration Statement to Raise up to USD17.5 Million in Public Offering of Shares 143
Table 66: Trovagene Plans to Raise Funds through Public Offering of Shares upon Exercise of Warrants 144
Table 67: T2 Biosystems Raises USD20 Million in Public Offering of Shares 145
Table 68: Thermo Fisher Scientific Prices Public Offering of Shares for USD1.5 Billion 147
Table 69: MetaStat Raises USD2.1 Million in First Tranche of Private Placement of Shares and Preferred Shares 149
Table 70: GenMark Diagnostics Prices Public Offering of Shares for USD75 Million 150
Table 71: Becton Dickinson Raises USD2.47 Billion in Public Offering of Shares 152
Table 72: Becton Dickinson Raises USD2.47 Billion in Public Offering of Depositary Shares 154
Table 73: HTG Molecular Diagnostics to Raise up to USD20 Million in Public Offering of Shares 156
Table 74: T2 Biosystems Files Registration Statement for Public Offering of Shares 157
Table 75: Corindus Vascular Robotics Raises USD45 Million in Private Placement of Shares 158
Table 76: Grail to Merge with Cirina 160
Table 77: OncoSec Medical Enters into Agreement with Jounce Therapeutics 161
Table 78: Singulex Enters into Agreement with Qiagen 162
Table 79: BioMedomics Raises USD0.5 Million in Venture Financing 163
Table 80: Biodesix Raises USD13.2 Million in Venture Financing 164
Table 81: Akonni Biosystems Raises USD4 Million in Venture Financing 165
Table 82: Armune BioScience Raises USD0.5 Million in Venture Financing 166
Table 83: Integrated Diagnostics Raises USD6 Million in Series C Financing 167
Table 84: Integrated Diagnostics Raises USD6.1 Million in Venture Financing 168
Table 85: Genalyte Raises USD36 Million in Series D Financing 169
Table 86: Total Number of Primary Research Participants, In Vitro Diagnostics Market, by Country 339

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available